The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND Antidepressant discontinuation symptoms are becoming an increasingly important part of clinical practice, but the incidence of antidepressant discontinuation symptoms has not been quantified. An estimate of antidepressant discontinuation symptoms incidence could inform patients and clinicians in the discontinuation of treatment, and provide useful information to researchers in antidepressant treatments. We aimed to assess the incidence of antidepressant discontinuation symptoms in patients discontinuing both antidepressants and placebo in the published literature. METHODS We systematically searched Medline, EMBASE, and CENTRAL from database inception until Oct 13, 2022 for randomised controlled trials (RCTs), other controlled trials, and observational studies assessing the incidence of antidepressant discontinuation symptoms. To be included, studies must have investigated cessation or tapering of an established antidepressant drug (excluding antipsychotics, lithium, or thyroxine) or placebo in participants with any mental, behavioural, or neurodevelopmental disorder. We excluded studies in neonates, and those using antidepressants for physical conditions such as pain syndromes due to organic disease. After study selection, summary data extraction, and risk of bias evaluation, data were pooled in random-effects meta-analyses. The main outcome was the incidence of antidepressant discontinuation symptoms after discontinuation of antidepressants or placebo. We also ana…
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The antidepressants associated with the highest incidence of individual discontinuation symptoms were venlafaxine and desvenlafaxine, consistent with previous studies and its rapid clearance.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Length of antidepressant treatment was not associated with discontinuation symptoms, consistent with previous meta-analyses.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [6]
In the citing paper
“Consistent with this, Henssler and colleagues6 found a 7% lower incidence when directly comparing placebo with antidepressant discontinuation.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [6]
In the citing paper
“Assessing symptoms using a nonstructured instrument may result in smaller ESs, as reported in another meta-analysis.”
From Incidence and Nature of Antidepressant Discontinuation Symptoms (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
How to perform a meta-analysis with R: a practical tutorial
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300117 · Cited by 5,827
Self-citationMethley, A. M., Campbell, S., Chew-Graham, C., McNally, R., & Cheraghi-Sohi, S. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0579-0 · Cited by 2,706
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis
Rucker, G., Schwarzer, G., Carpenter, J. R., Binder, H., & Schumacher, M. (2011) · Biostatistics · doi:10.1093/biostatistics/kxq046 · Cited by 286
Self-citationTapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Research works printed but not linked: 1
- Horowitz, 2023, Estimating risk of antidepressant withdrawal from a review of published data, CNS Drugs, 37, 143, 10.1007/s40263-022-00960-y · DOI · Paper page
Cited by
Umbrella reviews: a methodological guide
Fernandez, R. S., Sharifnia, A. M., & Khalil, H. (2025) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvaf012 · Cited by 93
Incidence and Nature of Antidepressant Discontinuation Symptoms
Kalfas, M., Tsapekos, D., Butler, M., McCutcheon, R. A., Pillinger, T., Strawbridge, R., Bhat, B. B., Haddad, P. M., Cowen, P. J., Howes, O. D., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1362 · Cited by 42
Stimpfl, J. N., Walkup, J. T., Robb, A. S., Alford, A. E., Stahl, S. M., McCracken, J. T., Stancil, S. L., Ramsey, L. B., Emslie, G. J., & Strawn, J. R. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0099 · Cited by 32
“…(Rickels et al., 2010) and depressive disorders, gradual and more rapid discontinuation approaches for antidepressants (Fava et al., 2015; Horowitz and Taylor, 2019; Rosenbaum et al., 1998; Tint et al., 2008), and the risk of withdrawal symptoms across medication classes (Henssler et al., 2024).”
Horowitz, M. A., Buckman, J. E. J., Saunders, R., Aguirre, E., Davies, J., & Moncrieff, J. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116497 · Cited by 25
Malhi, G. S., Bell, E., Stavdal, A., Wu, C., Naylor, A., & Kumari, V. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00201-1 · Cited by 22
Metadata
- Authors
- Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C.
- Affiliations
- University of Cologne (DE)
- University of Freiburg (DE)
- University Hospital Carl Gustav Carus (DE)
- Corresponding author
- Baethge, Christopher
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 11
- Issue
- 7
- Pages
- 526-535
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W4399370371
- Cited by
- 106
- References
- 25
- Citations by year
- 2026: 43 · 2025: 41 · 2024: 22
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Update notices
- erratum (2024-09-01)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Psychiatry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Bildung und Forschung (01KG1808)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressant discontinuation, antidepressant tapering, incidence, depression, mental illness, neurodevelopmental disorders, treatment discontinuation, meta-regression, sensitivity analysis, risk of bias, publication bias, heterogeneity
- MeSH terms
- Antidepressive Agents, Humans, Substance Withdrawal Syndrome, Incidence, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/s2215-0366(24)00133-0
- The paper
- Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024). Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(24)00133-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.